Phase 1 Clinical Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

 

ClinicalTrials.gov Identifier: NCT04234048

LinkedIn
Facebook
YouTube
Twitter - #SciTechUSA - SciTech Development
Instagram
SlideShare
Pinterest - SciTech Development
google icon

For investment and partnering opportunities contact:

Earle Holsapple  | 

© 2017-2020 SciTech Development LLC